How many people have Parkinsonโs disease? You may have heard the statistic that there are approximately one million people with Parkinsonโs disease (PD) living in the US. That means approximately 1 out of every 336 people are living with PD. That number has increased in past decades and will continue to increase. ย With a new […]
Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

Exciting New Parkinsonโs Disease Research is Underway On September 5, 2024, APDA announced 20 new Parkinsonโs disease (PD) research grants, for a total of $ 2.6 million in funding for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinsonโs disease (PD) and to develop new treatments and eventually, a […]
The Heart of The Matter: Cardiovascular Effects of Parkinsonโs Disease
It has long been understood that Parkinsonโs disease (PD) does not just cause movement, or motor, symptoms, but also causes a litany of non-motor symptoms with effects throughout the body. One of the organ systems that is affected is the cardiac system, encompassing the heart, as well as the major and minor blood vessels.
What is a DaTscan and should I get one?
DaTscan: A test to help in the diagnosis of Parkinson’s What is a DaTscan and how is it performed? In 2011, the Food and Drug Administration (FDA) approved an imaging test to help diagnose Parkinson’s disease (PD) called DaTscan (dopamine transporter scan). In this test, a radioactive tracer, Ioflupane (123I), also known as DaTscan, is injected […]
Gene therapy for Parkinsonโs disease
What is gene therapy and can it help people with Parkinsonโs? You may have read about efforts to use gene therapy as a treatment for Parkinsonโs disease (PD). Itโs an exciting prospect and studies are underway, with some positive results so far. Understanding these studies and therapies requires some background information about what genes are […]
Understanding Stem Cell Therapy in Parkinsonโs Disease Treatment
Lewy Bodies, Dementia, and Parkinson’s โ What Does it all Mean?
Understanding Cognitive Challenges in Parkinsonโs Disease: PDD vs. DLB Cognitive challenges are a very common non-motor symptom of Parkinsonโs disease (PD). When the cognitive challenges are severe enough to interfere with daily activity, they are known as Parkinsonโs disease dementia (PDD). You may have heard of another condition called Dementia with Lewy Bodies (DLB). Although […]
Carbidopa/Levodopa: Side Effects, Dosages, and More
What Worsens Parkinsonโs Disease’s Motor Symptoms?
Understanding what factors may worsen Parkinsonโs symptoms Many people with Parkinsonโs disease (PD) experience variation in their motor symptoms (e.g. tremor, stiffness, slowness, trouble walking, balance difficulties) throughout the day and from one day and the next. This variability is often related to medication dosing, and you and your doctor may focus on adjusting the […]
What We Know About Parkinsonโs Disease in Women
Differences of Parkinsonโs Disease in Women Parkinsonโs disease (PD) impacts millions of people around the world, and it does not discriminate based on gender. But while PD affects men and women with some similarities, the manifestation, progression, and even treatment responses can differ significantly between genders, in addition to important discrepancies related to healthcare access […]
Categories
- Advanced Parkinsonโs
- Care Partners
- Clinical Trials & PD
- COVID-19 & PD
- Digital Digest Articles
- Exercise
- Genetics & PD
- Intimacy & PD
- Living with Parkinson's
- Medication
- News
- Press Release
- Profiles in Parkinson's
- Research
- Risk Factors for Parkinson's
- Simplified Chinese
- Spanish
- Speech & PD
- Symptoms
- Training Courses
- Treatments
- Uncategorized
- Veterans
- What is Parkinson's
- Young Onset Parkinson's